文献速递创伤与烧伤重症综合管理与镇静镇痛

多发肋骨骨折合并中重度创伤性脑损伤患者行肋骨骨折手术稳定与非手术治疗后的结局比较(CWIS-TBI)

Outcome after surgical stabilization of rib fractures versus nonoperative treatment in patients with multiple rib fractures and moderate to severe traumatic brain injury (CWIS-TBI).
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论多发肋骨骨折合并TBI患者中,SSRF与无机械通气天数无差异,但肺炎风险和30天死亡率显著更低,尤其重度TBI患者30天死亡率更低。

这项多中心回顾性队列研究纳入2012年1月至2019年7月456例多发肋骨骨折合并TBI患者,其中111例(24.3%)接受SSRF,SSRF中位实施时间为3天,SSRF相关并发症率为3.6%。多因素分析显示SSRF组与保守治疗组无机械通气天数无差异,但SSRF组肺炎风险(OR 0.59,95%CI 0.38-0.98,p=0.043)和30天死亡率(OR 0.32,95%CI 0.11-0.91,p=0.032)显著更低。中度TBI(GCS 9-12)两组结局相似;重度TBI(GCS≤8)患者中SSRF组30天死亡率显著更低(OR 0.19,95%CI 0.04-0.88,p=0.034)。这些数据提示SSRF在特定TBI患者中可能具有作用。

要点

  • 456例多发肋骨骨折合并TBI患者中,111例(24.3%)接受SSRF,中位实施时间3天,SSRF相关并发症率3.6%。
  • SSRF组与保守组无机械通气天数无差异;SSRF组肺炎风险显著更低(OR 0.59,95%CI 0.38-0.98,p=0.043)。
  • SSRF组30天死亡率显著更低(OR 0.32,95%CI 0.11-0.91,p=0.032)。
  • 重度TBI(GCS≤8)患者中SSRF组30天死亡率显著更低(OR 0.19,95%CI 0.04-0.88,p=0.034);中度TBI(GCS 9-12)两组结局相似。
  • 证据等级为治疗性level IV,原文提示SSRF在特定TBI患者中可能具有作用。

适用人群与场景

  • 多发肋骨骨折合并创伤性脑损伤(TBI)患者,纳入时间为2012年1月至2019年7月。
  • 按GCS分层:中度TBI(GCS评分9-12)和重度TBI(GCS评分≤8)。
  • 原文未提及排除人群及具体急诊/ICU/院前场景。

诊断标准与关键阈值

  • TBI严重程度分层标准:中度TBI为GCS评分9-12,重度TBI为GCS评分≤8。

处置流程与药物剂量

  • SSRF组行手术稳定肋骨骨折,中位实施时间为3天;原文未提及具体手术方式、药物剂量及围术期方案。
  • 非手术组行保守治疗;原文未提及具体保守治疗方案。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • SSRF中位实施时间3天,SSRF相关并发症率3.6%。
  • 主要终点:无机械通气天数在SSRF组与保守组间无差异。
  • 次要终点:SSRF组肺炎风险显著更低(OR 0.59,95%CI 0.38-0.98,p=0.043);SSRF组30天死亡率显著更低(OR 0.32,95%CI 0.11-0.91,p=0.032)。
  • 中度TBI(GCS 9-12)患者两组结局相似;重度TBI(GCS≤8)患者SSRF组30天死亡率显著更低(OR 0.19,95%CI 0.04-0.88,p=0.034)。
  • 原文未提及ICU住院时长、医院住院时长、气管切开、并发症发生、神经功能结局及死亡率的组间具体数值。

证据类型、等级与局限

  • 证据类型:多中心、回顾性队列研究;证据等级:治疗性level IV。
  • 原文未述局限性。

对床旁实践的改变

  • 原文数据提示SSRF在特定TBI患者中可能具有作用;对多发肋骨骨折合并TBI患者,SSRF与保守治疗相比无机械通气天数无差异,但肺炎风险和30天死亡率更低,重度TBI患者30天死亡率更低。
  • 中度TBI(GCS 9-12)患者两组结局相似。
  • 原文未提及适用与不适用人群的具体标准及常见陷阱。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Outcomes after surgical stabilization of rib fractures (SSRF) have not been studied in patients with multiple rib fractures and traumatic brain injury (TBI). We hypothesized that SSRF, as compared with nonoperative management, is associated with favorable outcomes in patients with TBI.

METHODS: A multicenter, retrospective cohort study was performed in patients with rib fractures and TBI between January 2012 and July 2019. Patients who underwent SSRF were compared to those managed nonoperatively. The primary outcome was mechanical ventilation-free days. Secondary outcomes were intensive care unit length of stay and hospital length of stay, tracheostomy, occurrence of complications, neurologic outcome, and mortality. Patients were further stratified into moderate (GCS score, 9-12) and severe (GCS score, ≤8) TBI.

RESULTS: The study cohort consisted of 456 patients of which 111 (24.3%) underwent SSRF. The SSRF was performed at a median of 3 days, and SSRF-related complication rate was 3.6%. In multivariable analyses, there was no difference in mechanical ventilation-free days between the SSRF and nonoperative groups. The odds of developing pneumonia (odds ratio [OR], 0.59; 95% confidence interval [95% CI], 0.38-0.98; p = 0.043) and 30-day mortality (OR, 0.32; 95% CI, 0.11-0.91; p = 0.032) were significantly lower in the SSRF group. Patients with moderate TBI had similar outcome in both groups. In patients with severe TBI, the odds of 30-day mortality was significantly lower after SSRF (OR, 0.19; 95% CI, 0.04-0.88; p = 0.034).

CONCLUSION: In patients with multiple rib fractures and TBI, the mechanical ventilation-free days did not differ between the two treatment groups. In addition, SSRF was associated with a significantly lower risk of pneumonia and 30-day mortality. In patients with moderate TBI, outcome was similar. In patients with severe TBI a lower 30-day mortality was observed. There was a low SSRF-related complication risk. These data suggest a potential role for SSRF in select patients with TBI.

LEVEL OF EVIDENCE: Therapeutic, level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Prins JTH, Van Lieshout EMM, Ali-Osman F, et al. Outcome after surgical stabilization of rib fractures versus nonoperative treatment in patients with multiple rib fractures and moderate to severe traumatic brain injury (CWIS-TBI). J Trauma Acute Care Surg. 2021. PMID: 33093293. doi:10.1097/TA.0000000000002994

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。